The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
- 10 May 2024
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 593, 216951
Abstract
No abstract availableKeywords
Funding Information
- Beijing Xisike Clinical Oncology Research Foundation (Y-2019AZQN-0511)
- National Natural Science Foundation of China (82172744)
- Science and Technology Commission of Shanghai Municipality (21Y11913700)
This publication has 77 references indexed in Scilit:
- Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinomaCancer Cell, 2023
- Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapyCancer Cell, 2023
- An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinomaCancer Cell, 2023
- An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomesCancer Cell, 2022
- Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancerCancer Cell, 2022
- LBA3 Safety and efficacy of pembrolizumab combined with paclitaxel and cisplatin as a neoadjuvant treatment for locally advanced resectable (stage III) esophageal squamous cell carcinoma (Keystone-001): Interim analysis of a prospective, single-arm, single-center, phase II trialAnnals of Oncology, 2021
- S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesisClinical and Translational Medicine, 2021
- LAMC1 upregulation via TGFβ induces inflammatory cancer‐associated fibroblasts in esophageal squamous cell carcinoma via NF‐κB–CXCL1–STAT3Molecular Oncology, 2021
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in MelanomaCell, 2019
- Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative ColitisCell, 2019